Some targets that have been explored in combating inflammation relating to cancer include COX, NF-kB, cytokines/chemokines and their receptors, and fibroblast growth factor (FGF) and its receptor, as well as vascular endothelial growth factor [50]. This evidence concerns the gene NFKB1 and cancer.